Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07426458 · ClinicalTrials.gov registry record · Phase 4
Ventilation and Perfusion in Asthmatics
A Phase 4 study, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT07426458 is a Phase 4 study that is actively recruiting participants, run by University of Miami. The registered enrollment target is 40 participants.
The verdict
NCT07426458, a Phase 4 study, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).
Interventions
- DRUG Albuterol Sulfate
- DRUG Albuterol-Budesonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04-27 |
| Est. Completion | 2028-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07426458
The ClinicalTrials.gov registry entry for NCT07426458 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Albuterol Sulfate is the first listed.
NCT07426458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07426458 about?
NCT07426458 is a clinical study titled "Ventilation and Perfusion in Asthmatics". Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (...
What is the current status of trial NCT07426458?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2026-04-27. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07426458?
The interventions under investigation include: Albuterol Sulfate (DRUG), Albuterol-Budesonide (DRUG).
Who is sponsoring clinical trial NCT07426458?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.